コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nown electron acceptors, benzyl viologen and ferricyanide.
2 cyte lysates treated with an oxidant such as ferricyanide.
3 et state of rose bengal and its quenching by ferricyanide.
4 ytochrome by semidehydroascorbate but not by ferricyanide.
5 electrode (1-mm diameter) in the presence of ferricyanide.
6 but was inhibited at high concentrations of ferricyanide.
7 found to refold partially on oxidation with ferricyanide.
8 th for the reduction of biotin sulfoxide and ferricyanide.
9 -isoprostane formation due to extravesicular ferricyanide.
10 tochrome c, 2,6-dichlorophenolindophenol, or ferricyanide.
11 f intravesicular ascorbate by extravesicular ferricyanide.
12 ion containing the redox marker ferrocyanide/ferricyanide.
13 ive coupling species in situ using potassium ferricyanide.
14 and increase in peak splitting for potassium ferricyanide.
15 rons from intracellular Asc to extracellular ferricyanide.
16 antioxidant properties of vitamin C against ferricyanide.
17 2p to carry the NADPH-dependent reduction of ferricyanide.
18 the paramagnetic broadening agent potassium ferricyanide.
19 osed to a trans-membrane oxidant stress from ferricyanide.
20 xidized by either hydrogen peroxide, air, or ferricyanide.
21 +) form by treatment with a 3-fold excess of ferricyanide.
22 uction of the artificial electron acceptors: ferricyanide, 2,6-dichloroindophenol, 3-acetylpyridine a
25 , largely superoxide dismutase-independent), ferricyanide (470 min(-1)), and other electron acceptors
28 ide reduction kinetic analysis (variation of ferricyanide absorption with time), much more sensitive
31 the kinetics of NO release before and after ferricyanide addition in tissue homogenates to mathemati
32 T, test cells were treated with drugs before ferricyanide addition; cell counts from the amperometric
33 , the mass-transport controlled reduction of ferricyanide, allows for a proof of principle evaluation
35 uring purification and to use both potassium ferricyanide and 2,6-dichloroindophenol as electron acce
36 dditionally, two unpoised systems (potassium ferricyanide and ascorbic acid) were studied to evaluate
38 and flow modes were evaluated using aqueous ferricyanide and compare favorably to those reported pre
39 from MoR, has similar kinetic properties for ferricyanide and cytochrome c reductase activities and v
40 sures of flavin and heme reduction kinetics, ferricyanide and cytochrome c reduction, and NO synthesi
42 resuspension, incubation in the presence of ferricyanide and finally ferrocyanide amperometry in dru
45 ity of the electrodes using the test analyte ferricyanide and perform recordings of quantal exocytosi
47 phenol-indophenol, 2) the iron (III) complex ferricyanide, and 3) the keto-acids oxaloacetate and pyr
51 he pH response while quinhydrone, ferro- and ferricyanide, and sodium sulfide have marked effects.
52 oactive potassium ferrocyanide and potassium ferricyanide, and supporting electrolyte, potassium chlo
53 and Lys-146 were much more accessible to the ferricyanide anion in the apoE3.DMPC complex than in the
54 of the substrates cytochrome c and potassium ferricyanide approximately 100-fold, while substitution
57 metric analysis was performed with potassium ferricyanide as an electron mediator under argon or atmo
58 The A129T MSR mutant transfers electrons to ferricyanide as efficiently as wild type MSR but the rat
62 is-light electron generating system, reduces ferricyanide at a rate of 1.8 mumol/min/ nmol reductase.
63 inone was unusually insensitive to oxygen or ferricyanide at pH 8 and showed absorbance peaks at 372
64 ase domain of CYPOR reduced cytochrome c and ferricyanide at rates 2-fold higher than that of native
65 N-bound reductase catalyzes the reduction of ferricyanide at rates of 0.43 and 0.28 mumol/min/ nmol r
67 tive chemiluminescence in conjunction with a ferricyanide-based hemoglobin oxidation assay to prevent
69 cts were blocked by myoglobin oxidation with ferricyanide but not by the xanthine oxidoreductase inhi
72 icted by the Beer-Lambert law for a range of ferricyanide concentrations from 0.005 to 0.3 mM and sho
73 from Ludox, ferrocenemethanol and potassium ferricyanide diffused at rates identical to that measure
74 ghosts with the membrane-impermeant oxidant ferricyanide doubled the ghost membrane concentration of
75 ed to quantitatively detect the reduction of ferricyanide down to a concentration of approximately 10
78 a recently described modified assay using a ferricyanide-enhanced reaction mix at biologically relev
80 the proof-of-concept experiments described, ferricyanide, Fe(CN)6(3-), was produced by the transport
81 sed one-electron transfer systems (potassium ferricyanide/ferrocyanide and ferrous/ferric ammonium su
82 e anodic inlet and another drop of potassium ferricyanide for cathodic reaction flowed through patter
83 of contrast with osmium tetroxide/potassium ferricyanide, for BSE imaging, for the preparation and p
84 sulfite followed by partial reoxidation with ferricyanide generates an EPR spectrum with g-values sim
86 blood when MetHb formers, such as potassium ferricyanide, hydroxylamine, sodium nitrite, and 4-dimet
87 ial recovery of enzyme activity by potassium ferricyanide illuminated an alternative irreversible mec
88 tic activity do not support the reduction of ferricyanide in the Tris-light system in the absence of
89 on acceptors (molecular oxygen, APAD(+), and ferricyanide), in the presence and absence of a competit
90 h potential oxidant, such as cytochrome c or ferricyanide, in the presence of phospholipid vesicles o
92 ate resealed within ghosts protected against ferricyanide-induced oxidation of endogenous alpha-tocop
93 mmol/L nitroblue tetrazolium and 0.1 mmol/L ferricyanide) inhibited pulmonary artery relaxation to n
95 ricyanide to the assay buffer; the effect of ferricyanide is attributed to oxidation of H2O2-dismutat
97 tro-oxidation of ferrocyanide, produced when ferricyanide is reduced by bacterial electron-transport.
98 A double mediator system is used in which ferricyanide is the final electron acceptor (the reporte
99 F-kappaB activation by hydrogen peroxide and ferricyanide, it had no effect of tumor necrosis factor-
102 d biomass) and 550 nm (biomass), allowed for ferricyanide monitoring without interference of biomass
104 ical signals from a soluble redox indicator, ferricyanide, on nitrocellulose films treated by cellula
105 f the nNOS heme or cytochrome c, but not for ferricyanide or dichlorophenolindolphenol, and establish
107 sitive to oxygen, and ferric sGC prepared by ferricyanide oxidation has a 5c high-spin heme complex.
110 ster using conventional methods of oxygen or ferricyanide oxidation or thiol exchange were not succes
116 eptors such as 2,6-dichlorophenolindophenol, ferricyanide, quinones, and molecular oxygen (O(2)).
117 rea of electrodes becoming accessible to the ferricyanide reaction after nitrocellulose digestion by
118 g a change in the reaction kinetics of ferro-ferricyanide redox couple at the electrode upon hybridiz
119 (SWV) reduction peak signal of ferrocyanide/ferricyanide redox couple due to the removal of the nega
120 l change alters the access of a ferrocyanide/ferricyanide redox couple to the aptasensor surface.
125 he effects of viscosogen on cytochrome c and ferricyanide reductase activities of holo-NaR and ferric
126 xhibited a low level of the cytochrome c and ferricyanide reductase activities, which either did not
127 had slower NADPH-dependent cytochrome c and ferricyanide reductase activities, which were associated
130 ed antibody immunoprecipitated both the NADH-ferricyanide reductase activity and NADH-coenzyme Q(0) r
133 cyanide reductase activities of holo-NaR and ferricyanide reductase activity of the recombinant molyb
135 thracycline antitumor agents and a candidate ferricyanide reductase for plasma membrane electron tran
136 ly lower (<or=1000x) cytochrome c reductase, ferricyanide reductase, and NADPH oxidase activities tha
138 NH2-FAD, and riboflavin, are able to support ferricyanide reduction at a rate of 0.40, 0.52, 0.87, an
139 -reconstituted FMN-bound reductase catalyzes ferricyanide reduction at a rate of 1.1 mumol/min/nmol r
140 reductase in this system is able to catalyze ferricyanide reduction at a rate of 1.6 mumol/ min/nmol
141 1412D nNOS catalyzed faster cytochrome c and ferricyanide reduction but displayed slower steady-state
142 NADPH oxidation, cytochrome c reduction, and ferricyanide reduction by full-length eNOS or its isolat
144 sed on dual wavelength analysis of bacterial ferricyanide reduction kinetics is presented, using Esch
147 s measured indirectly as ascorbate-dependent ferricyanide reduction, correlated with the content of a
148 influence eNOS oxygenase domain function or ferricyanide reduction, it does potentiate the ability o
150 ive titrations with dithionite and potassium ferricyanide, respectively, show that FAD is the only re
152 esponse of redox active molecules (potassium ferricyanide, ruthenium(III) hexammine, and ferrocene me
153 um or heparinized blood containing potassium ferricyanide showed ideal voltammetry while significant
154 Shift reagent experiments with potassium ferricyanide showed that Lys-143 and Lys-146 were much m
156 molecular recognition element, and the ferro/ferricyanide solution as a redox probe, was developed.
158 een demonstrated via measurements on aqueous ferricyanide solutions using sample volumes as low as 20
159 sarcoplasmic reticulum (visualized by osmium ferricyanide staining of thin tissue sections), which su
161 H, Q-1, and the artificial electron acceptor ferricyanide strongly support an electron transport path
162 s the pi-back-bonding features in ferro- and ferricyanide that are significantly more intense in L-ed
164 pair, and with the weak one-electron oxidant ferricyanide, the OG nucleoside reactivity is >6000-fold
166 ials down to -650 mV, but can be oxidized by ferricyanide to an S = 1/2 [4Fe-4S]3+ state (g = 2.09, 2
167 ar spin I = 3/2), followed by reoxidation by ferricyanide to generate the Mo(V) state of the active c
168 but was completely suppressed by adding 5 mM ferricyanide to the assay buffer; the effect of ferricya
174 ochrome c, 2,6-dichlorophenolindophenol, and ferricyanide was inhibited by the addition of any of the
180 constant-potential electrolysis of potassium ferricyanide were used to characterize this rotating sam
181 releases NO at neutral pH in the presence of ferricyanide when reacted with an Fe(III) ligand like az
182 ponses at cathodic peak (+0.2V) of potassium ferricyanide, whereas pyruvate concentration was determi
183 cal impedance spectroscopy with ferrocyanide/ferricyanide, which revealed a very low charge-transfer
186 ata of cyclic voltammetry with 1mM potassium ferricyanide) with respect to conventional electrodes te
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。